financial guidance Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 The guidance for next year assumes, among other things, $6.0 billion in revenue from clinical research services provider PPD, which Thermo Fisher is set to acquire this year. LumiraDx, CA Healthcare Acquisition Revise Merger Terms to Lower Equity Value of Combined Company The firms said that lowering the pro forma enterprise value of post-merger LumiraDx is expected to make the new company more attractive to investors. SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent The company said that it expects to exceed its previous full-year 2021 guidance of $66.7 million in revenues by 10 percent or more. Agilent Technologies Q3 Revenues Rise 26 Percent Revenues for Agilent's diagnostic and genomics group rose 44 percent to $346 million from $241 million in the year-ago quarter. 23andMe Q1 Revenues Rise 23 Percent The company said its revenue growth was primarily due to higher sales of its Personal Genome Service kit. Jul 28, 2016 Thermo Fisher Scientific Reports 6 Percent Rise in Q2 Revenues; Inks Chinese MDx Development Deal Jul 27, 2016 Hologic Q3 Revenues Up 3 Percent Jul 26, 2016 Exact Sciences Revenues More Than Double on Cologuard Sales Jul 25, 2016 Danaher Reports 17 Percent Spike in Q2 Revenues; Restructures Reporting Segments Jun 9, 2016 Luminex Sees Revenue Growth at High End of Guidance; Provides Update on Nanosphere Deal May 18, 2016 Quest Wraps Up Effort to Refocus on Dx Information Services; Lowers 2016 Revenue Guidance May 10, 2016 WaferGen Biosystems Q1 Revenues Up 68 Percent May 6, 2016 CareDx Revenues Drop 8 Percent in Q1 May 3, 2016 UPDATE: Exact Sciences Revenues Up More Than Twofold on Cologuard Sales May 2, 2016 Luminex Q1 Revenues Up 9 Percent Apr 28, 2016 Thermo Fisher Reports Q1 Revenues Up 10 Percent, Raises Full-Year Guidance Apr 28, 2016 Meridian Bioscience Reports Drop in Q2 Revenues, Earnings Apr 27, 2016 Hologic Q2 Revenues Up 6 Percent Mar 8, 2016 Natera Q4 Revenues Rise 6 Percent as Number of Accessioned Tests Balloons 56 Percent Feb 24, 2016 Nanosphere Q4 Revenues Rise 48 Percent Feb 23, 2016 GenMark Diagnostics' Q4 Revenues Rise 34 Percent Feb 18, 2016 MDxHealth Q4 Revenues Rise 68 Percent Feb 2, 2016 Qiagen Q4 Sales Drop 3 Percent on Currency Effects Jan 27, 2016 Meridian Bioscience Q1 Revenues Fall 2 Percent Jan 26, 2016 Danaher Q4 Revenues Rise 13 Percent Load More Breaking News Exome Sequencing of UK Biobank Participants Highlights Natural Variation, Gene Function Cystic Fibrosis Sinus Infections Involve Microbes With Shifting Evolution Patterns Molecular Assemblies Wins $256K NIH Phase I SBIR Grant to Develop Enzymatic DNA Synthesis Vibrent Health, VCU Partner to Offer Twin Research Platform Castle Biosciences Acquires Cernostics for up to $80M Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies The Scan Could Mix It Up The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says. Closest to the Dog New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs. Offer to Come Back The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back. PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.